Abrilada

Abrilada Description

adalimumab

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
Each 0.8 ml single dose pre-filled pen contains 40 mg of adalimumab.
Adalimumab is a recombinant human monoclonal antibody produced in Chinese hamster ovary cells.
ABRILADA is a biosimilar medicine to HUMIRA. The evidence for comparability supports the use of ABRILADA for the listed indications. Abrilada is not interchangeable or automatically substitutable with Adalimumab.
Excipients/Inactive Ingredients: L Histidine, L Histidine hydrochloride monohydrate, Sucrose, Edetate Disodium Dihydrate, L Methionine, Polysorbate 80, Water for injections.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in